NEFCARE: INOVASI SMART BRACELET TERINTEGRASI TELEMEDICINE (TELECONSULTATION, TELEMONITORING, AND TELENUTRITION) UNTUK MENINGKATKAN QUALITY OF LIFE PASIEN GINJAL KRONIS DENGAN HEMODIALISIS
Main Article Content
Abstract
Chronic Kidney Disease (CKD) is a global health problem that continues to experience an increase in cases every year and has affected more than 200 million people throughout the world. This data is linear with the results of Basic Health Research (RISKESDAS) in 2018 which indicated that there was an increase of around 60% of kidney failure sufferers who had to undergo hemodialysis. Hemodialysis (HD) itself is a method of dialysis therapy which aims to remove fluid and metabolic waste substances accurately because the kidneys are no longer able to carry out this mechanism. The treatment process is not short and requires high discipline, causing hemodialysis patients to experience various psychological problems in the form of excessive stress and physiological problems related to dehydration. Ironically, PGK is also a neglected disease, as evidenced by the lack of development of wireless monitoring tools for patient health conditions. The purpose of writing this scientific work is to determine the potential for realization and effectiveness of a technology called "NEFCARE" which is a combination of a smart bracelet with telemedicine (teleconsultation, telemonitoring, and telenutrition) based on literature studies that have been carried out in the last 10 years of publication. The databases used came from NCBI, PubMed, and ScienceDirect using the keywords "Hemodialysis", "Telemedicine", "Chronic Kidney Disease", "QoL". There are 15 valid and reliable articles based on inclusion criteria which state that the development of wireless technology specifically for CKD patients, especially hemodialysis, can improve the quality of life of patients psychologically and physiologically, as well as prevent complications from other diseases. In the "NEFCARE" innovation, the smart bracelet developed uses temperature and blood pressure parameter sensors with display reminders related to rest, medication consumption, eating and drinking, and physical activity; Furthermore, the Android application presents several questions as indicators of stress levels, teleconsultation and telenutrition which are connected directly to medical professionals, as well as telemonitoring which can be monitored independently by the patient as a progress during treatment. There is great hope that this innovation can become an alternative for CKD patients to improve their quality of life
Article Details
References
Cappon, G., Accardo, A., Vadalà, G., Rundo, F., Zappia, C., & Lombardo, C. (2020). IoT-Based Blood Glucose Monitoring System for Diabetes Management. Sensors, 20(23), 6870.
Cheng, P.-C. and Kao, C.-H. 2021 ‘Telemedicine assists in the management of proatherogenic dyslipidemia and postprandial glucose variability in patients with type 2 diabetes mellitus: a cross-sectional study’, Endocrine Connections, 10(7), pp. 789–795. doi: 10.1530/ec 21-0209.
Choudhury, A., Mukherjee, S., & Ghosh, S. K. (2019). Internet of Things in Healthcare: A Comprehensive Study. Journal of Ambient Intelligence and Humanized Computing, 10(12), 4571–4596.
Cole, J.B. And Florez, J.C., 2020. Genetics Of Diabetes Mellitus and Diabetes Complications. Nature Reviews Nephrology, 16(7), Pp.377-390.
Hanckel, B., Petticrew, M., Thomas, J., & Green, J. 2021. The use of Qualitative Comparative Analysis (QCA) to address causality in complex systems: a systematic review of research on public health interventions. BMC public health, 21(1), 1-22.
Jeong, J. Y. et al. (2018) ‘Smart Care Based on Telemonitoring and Telemedicine for Type 2 Diabetes Care: Multi-Center Randomized Controlled Trial’, Telemedicine and e-Health, 24(8), pp. 604–613. doi:
10.1089/tmj.2017.0203.
Kumar, P., Lee, W. J., & Oh, H. (2020). IoT-Based Healthcare Systems Using Wearable Sensors: A Review. Sensors, 20(12), 3466.
Ma, L., & Fu, H. (2020). Exploring the influence of project complexity on the mega construction project success: a qualitative comparative analysis (QCA) method. Engineering, Construction and Architectural Management, 27(9), 2429-2449.
Margolis, K. L. et al. (2018) ‘Long-term Outcomes of the Effects of Home Blood Pressure Telemonitoring and Pharmacist Management on Blood Pressure Among Adults Uncontrolled With Hypertension: Follow-up of a Cluster
Randomized Clinical Trial’, JAMA network open, 1(5), p. e181617. doi: 10.1001/jamanetworkopen.2018 .1617.
Oguntibeju, O.O., 2019. Type 2 Diabetes Mellitus, Oxidative Stress and Inflammation: Examining the Links. International Journal of Physiology, Pathophysiology and Pharmacology, 11(3), P.45.
Pinar, U. et al. (2020) ‘Preliminary assessment of patient and physician satisfaction with the use of teleconsultation in urology during the COVID-19 pandemic’, World Journal of Urology, 39(6), pp. 1991–1996. doi: 10.1007/s00345-02003432-4.
Rahmani, A. M., Thanigaivelan, N. K., Gia, T. N., Granados, J., Negash, B., & Alelaiwi, A. (2018). Smart e-Health Gateway: Bringing Intelligence to Things Based Internet-of Ubiquitous Healthcare Systems. Journal of Ambient Intelligence and Humanized Computing, 9(2), 281–297.
Rajan, R., Kaur, M., & Khosla, A. (2019). IoT-Based Continuous Glucose Monitoring System for Diabetes Mellitus: An Analysis of Challenges and Solutions. Journal of Ambient Intelligence and Humanized Computing, 10(12), 4553–4570.
Sabesan, S. et al. (2014) ‘A tele-oncology model replacing face-to-face specialist cancer care: Perspectives of patients in North Queensland’, Journal of Telemedicine and Telecare, 20(4), pp. 207–211. doi: 10.1177/1357633X14529237.
Tan, J. et al. (2018) ‘Telenephrology: Providing Healthcare to Remotely Located Patients with Chronic American Kidney Disease’, Journal of Nephrology, 47(3), pp. 200–207. doi: 10.1159/000488004.
Wijayanti, R. P., & Wijaya, A. B. (2020). Peran Internet of Things (IoT) dalam Pemantauan Diabetes Mellitus. Jurnal Kesehatan Masyarakat (Journal of Public Health), 18(1), 9-19.
Wild, S. H. et al. (2016) ‘Supported Telemonitoring and Glycemic Control in People with Type 2 Diabetes: The Telescot Diabetes Pragmatic Multicenter Randomized Controlled Trial’, PLoS Medicine, 13(7), pp. 1–16. doi:10.1371/journal.pmed.1002098.